JPMorgan raises Regeneron Pharmaceuticals (REGN.US) target price to $950
智通财经2026/10/06 04:41JPMorgan has raised the price target for Regeneron Pharmaceuticals (REGN.US) from $900 to $950.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays raises ASML Holding target price to 2,450 euros
Barclays has raised the target price of ASML Holding from 2,400 euros to 2,450 euros.
AMD CEO Lisa Su says AI security still needs improvement
Market News: AMD (AMD.US) CEO Lisa Su stated that there is still room for improvement in artificial intelligence security.
AMD CEO Lisa Su says the Super Intelligence Task Force will help coordinate the future
Market news: AMD (AMD.US) CEO Lisa Su stated that the Super Intelligence Task Force will facilitate future coordination.
AMD CEO Lisa Su stated that supply will be significantly increased in 2027.
Market news: AMD (AMD.US) CEO Lisa Su stated that the company will significantly increase supply in 2027.
Crypto prices
More
